Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes

Identifieur interne : 005325 ( Istex/Curation ); précédent : 005324; suivant : 005326

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes

Auteurs : Moses J. Bockarie [Papouasie-Nouvelle-Guinée] ; Neal De Alexander ; Philip Hyun [Papouasie-Nouvelle-Guinée] ; Zachary Dimber [Papouasie-Nouvelle-Guinée] ; Florence Bockarie [Papouasie-Nouvelle-Guinée] ; Ervin Ibam [Papouasie-Nouvelle-Guinée] ; Michael P. Alpers ; James W. Kazura [États-Unis]

Source :

RBID : ISTEX:B1517801DEFEBBA9C3C5D76423E9BD53763D99A0

Abstract

Background WHO has targeted lymphatic filariasis for elimination. Studies of vector-parasite relations of Wuchereria bancrofti suggest that a reduction in the microfilarial reservoir by mass chemotherapy may interrupt transmission and thereby eliminate infection. However, no field data exist on the impact of chemotherapy alone on vector efficiency and transmission intensity of W bancrofti. We compared the impact of an annual community-wide single-dose treatment with diethylcarbamazine alone or with ivermectin on rate and intensity of microfilaraemia, and transmission intensity in an area of Papua New Guinea endemic for intense W bancrofti transmission.Methods We carried out clinical and parasitological surveys in 14 communities in matched pairs. People aged 5 years or older in seven communities received randomly assigned diethylcarbamazine 6 mg/kg and people in the other seven communities received diethylcarbamazine 6 mg/kg plus ivermectin 400 g/kg. We made physical examinations for hydroceles and leg oedema and investigated microfilarial densities by membrane filtration before and after treatment. We selected five communities for monthly entomological surveys between September, 1993, and September, 1995. Mosquitoes were collected in these communities by the all-night landing catch method and were individually dissected to identify rates of infection and infectiveness.Findings 2219 (876) of 2534 eligible people received treatment. Microfilarial rate and density had decreased 1 year after treatment in all 14 communities; this decrease was significantly higher in communities given combined therapy than in those given diethylcarbamazine alone (mean decreases 575 and 306, respectively; p=00013). Greater decreases were also seen in community-specific microfilarial intensity with combined therapy (mean reductions 911 and 698, respectively; p=00047). The rate of leg oedema was not altered, but the frequency of advanced hydroceles decreased by 47 with combined therapy and 56 with diethylcarbamazine alone. 26641 Anopheles punctulatus mosquitoes were caught during 499 person-nights of landing catches. Exposure to infective third-stage larvae decreased in all monitored five communities. Annual transmission potential decreased by between 757 and 988 in combined-therapy communities and between 756 and 794 in communities given diethylcarbamazine alone. Transmission was almost interrupted in two communities treated with combined therapy.Interpretation Annual single-dose community-wide treatment with diethylcarbamazine alone or with ivermectin is effective for the control of lymphatic filariasis in highly endemic areas, but combination therapy brings about greater decreases in rates and intensity of microfilaraemia.

Url:
DOI: 10.1016/S0140-6736(97)07081-5

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:B1517801DEFEBBA9C3C5D76423E9BD53763D99A0

Curation

No country items

Neal De Alexander
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>
Michael P. Alpers
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes</title>
<author>
<name sortKey="Bockarie, Moses J" sort="Bockarie, Moses J" uniqKey="Bockarie M" first="Moses J" last="Bockarie">Moses J. Bockarie</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alexander, Neal De" sort="Alexander, Neal De" uniqKey="Alexander N" first="Neal De" last="Alexander">Neal De Alexander</name>
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hyun, Philip" sort="Hyun, Philip" uniqKey="Hyun P" first="Philip" last="Hyun">Philip Hyun</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dimber, Zachary" sort="Dimber, Zachary" uniqKey="Dimber Z" first="Zachary" last="Dimber">Zachary Dimber</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bockarie, Florence" sort="Bockarie, Florence" uniqKey="Bockarie F" first="Florence" last="Bockarie">Florence Bockarie</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ibam, Ervin" sort="Ibam, Ervin" uniqKey="Ibam E" first="Ervin" last="Ibam">Ervin Ibam</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alpers, Michael P" sort="Alpers, Michael P" uniqKey="Alpers M" first="Michael P" last="Alpers">Michael P. Alpers</name>
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kazura, James W" sort="Kazura, James W" uniqKey="Kazura J" first="James W" last="Kazura">James W. Kazura</name>
<affiliation wicri:level="1">
<mods:affiliation>Division of Geographic Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, 2109 Adalbert Road, Cleveland OH 44106, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Geographic Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, 2109 Adalbert Road, Cleveland OH 44106</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:B1517801DEFEBBA9C3C5D76423E9BD53763D99A0</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1016/S0140-6736(97)07081-5</idno>
<idno type="url">https://api.istex.fr/document/B1517801DEFEBBA9C3C5D76423E9BD53763D99A0/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">005325</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">005325</idno>
<idno type="wicri:Area/Istex/Curation">005325</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes</title>
<author>
<name sortKey="Bockarie, Moses J" sort="Bockarie, Moses J" uniqKey="Bockarie M" first="Moses J" last="Bockarie">Moses J. Bockarie</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alexander, Neal De" sort="Alexander, Neal De" uniqKey="Alexander N" first="Neal De" last="Alexander">Neal De Alexander</name>
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hyun, Philip" sort="Hyun, Philip" uniqKey="Hyun P" first="Philip" last="Hyun">Philip Hyun</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dimber, Zachary" sort="Dimber, Zachary" uniqKey="Dimber Z" first="Zachary" last="Dimber">Zachary Dimber</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bockarie, Florence" sort="Bockarie, Florence" uniqKey="Bockarie F" first="Florence" last="Bockarie">Florence Bockarie</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ibam, Ervin" sort="Ibam, Ervin" uniqKey="Ibam E" first="Ervin" last="Ibam">Ervin Ibam</name>
<affiliation wicri:level="1">
<mods:affiliation>Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea</mods:affiliation>
<country xml:lang="fr">Papouasie-Nouvelle-Guinée</country>
<wicri:regionArea>Papua New Guinea Institute of Medical Research, Madang</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Alpers, Michael P" sort="Alpers, Michael P" uniqKey="Alpers M" first="Michael P" last="Alpers">Michael P. Alpers</name>
<affiliation>
<mods:affiliation>Papua New Guinea Institute of Medical Research, Goroka</mods:affiliation>
<wicri:noCountry code="subField">Goroka</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kazura, James W" sort="Kazura, James W" uniqKey="Kazura J" first="James W" last="Kazura">James W. Kazura</name>
<affiliation wicri:level="1">
<mods:affiliation>Division of Geographic Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, 2109 Adalbert Road, Cleveland OH 44106, USA</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Geographic Medicine, Case Western Reserve University School of Medicine and University Hospitals of Cleveland, 2109 Adalbert Road, Cleveland OH 44106</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1998">1998</date>
<biblScope unit="volume">351</biblScope>
<biblScope unit="issue">9097</biblScope>
<biblScope unit="page" from="162">162</biblScope>
<biblScope unit="page" to="168">168</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Background WHO has targeted lymphatic filariasis for elimination. Studies of vector-parasite relations of Wuchereria bancrofti suggest that a reduction in the microfilarial reservoir by mass chemotherapy may interrupt transmission and thereby eliminate infection. However, no field data exist on the impact of chemotherapy alone on vector efficiency and transmission intensity of W bancrofti. We compared the impact of an annual community-wide single-dose treatment with diethylcarbamazine alone or with ivermectin on rate and intensity of microfilaraemia, and transmission intensity in an area of Papua New Guinea endemic for intense W bancrofti transmission.Methods We carried out clinical and parasitological surveys in 14 communities in matched pairs. People aged 5 years or older in seven communities received randomly assigned diethylcarbamazine 6 mg/kg and people in the other seven communities received diethylcarbamazine 6 mg/kg plus ivermectin 400 g/kg. We made physical examinations for hydroceles and leg oedema and investigated microfilarial densities by membrane filtration before and after treatment. We selected five communities for monthly entomological surveys between September, 1993, and September, 1995. Mosquitoes were collected in these communities by the all-night landing catch method and were individually dissected to identify rates of infection and infectiveness.Findings 2219 (876) of 2534 eligible people received treatment. Microfilarial rate and density had decreased 1 year after treatment in all 14 communities; this decrease was significantly higher in communities given combined therapy than in those given diethylcarbamazine alone (mean decreases 575 and 306, respectively; p=00013). Greater decreases were also seen in community-specific microfilarial intensity with combined therapy (mean reductions 911 and 698, respectively; p=00047). The rate of leg oedema was not altered, but the frequency of advanced hydroceles decreased by 47 with combined therapy and 56 with diethylcarbamazine alone. 26641 Anopheles punctulatus mosquitoes were caught during 499 person-nights of landing catches. Exposure to infective third-stage larvae decreased in all monitored five communities. Annual transmission potential decreased by between 757 and 988 in combined-therapy communities and between 756 and 794 in communities given diethylcarbamazine alone. Transmission was almost interrupted in two communities treated with combined therapy.Interpretation Annual single-dose community-wide treatment with diethylcarbamazine alone or with ivermectin is effective for the control of lymphatic filariasis in highly endemic areas, but combination therapy brings about greater decreases in rates and intensity of microfilaraemia.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005325 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 005325 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:B1517801DEFEBBA9C3C5D76423E9BD53763D99A0
   |texte=   Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024